Q2 2026 13F · SEC CIK 2044285

Dauntless Investment Group, LLC

Investment managerFiled 2026-08-13 for Q2 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value: $57.7M
Reported positions: 64
Holdings vs S&P 500, 3 yrs: —
Average holding period: 3 qtrs

Dauntless Investment Group, LLC is an investment manager that reported 64 positions worth $57.7M in its Q2 2026 13F, filed 2026-08-13. Its largest holdings were Aeon Biopharma Inc (15.6%), Femasys Inc (FEMY, 13.5%), Kazia Therapeutics Ltd (KZIA, 8.6%).

Dauntless Investment Group, LLC holdings largest 50 of 64 positions.

Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

Dauntless Investment Group, LLC 13F holdings
Stock	% of 13F value	Q1 2026	Shares	Share change	Reported value
00791X209Aeon Biopharma Inc	15.6%	7.0%	12,490,154	+394.1%	$9.0M
FEMYFemasys Inc	13.5%	—	1,867,987	—	$7.8M
KZIAKazia Therapeutics Ltd	8.6%	1.7%	354,208	+343.7%	$5.0M
VLOValero Energy Corp	4.8%	—	10,620	—	$2.8M
JOESt Joe Company	3.9%	5.7%	36,167	+12.1%	$2.3M
ADAGAdagene Inc	3.9%	0.4%	537,230	+1444.9%	$2.3M
ESTAEstablishment Labs Hldgs Inc	3.8%	1.5%	25,728	+172.9%	$2.2M
IRSIrsa Inversiones Y Rep S A	3.4%	—	126,542	—	$2.0M
05479L302Azitra Inc	3.3%	—	11,292,186	—	$1.9M
LINCLincoln Educational Srvcs	2.7%	6.8%	31,046	-47.8%	$1.5M
TLSATiziana Life Sciences Ltd	2.6%	7.1%	1,162,000	-46.3%	$1.5M
PROFProfound Med Corp	2.4%	4.4%	208,369	-13.4%	$1.4M
ARMPArmata Pharmaceuticals Inc	2.3%	2.6%	203,891	+125.1%	$1.3M
LOMALoma Negra C I A S A Mtn 14	2.3%	—	115,186	—	$1.3M
COURCoursera Inc	2.2%	1.4%	224,171	+154.2%	$1.3M
UTIUniversal Technical Inst Inc	2.1%	1.5%	27,990	+92.0%	$1.2M
QNRXQuoin Pharmaceuticals Ltd	1.8%	3.6%	214,987	+9.4%	$1.0M
NOWServicenow Inc	1.8%	—	10,200	—	$1.0M
UNCYUnicycive Therapeutics Inc	1.7%	2.7%	214,000	+45.5%	$1.0M
CRESYCresud S A C I F Y A	1.6%	—	80,186	—	$899K
TOIThe Oncology Institute Inc	1.5%	4.0%	163,570	-64.6%	$888K
PTCTPtc Therapeutics Inc	1.4%	1.6%	10,193	+21.9%	$831K
DRTSAlpha Tau Medical Ltd	1.3%	—	61,200	—	$770K
TLPHTalphera Inc	1.3%	0.9%	746,051	+71.4%	$768K
CCXIChurchill Cap Corp Xi	1.2%	—	38,587	—	$673K
MRXMarex Group PLC	1.1%	2.5%	10,324	-49.2%	$629K
MPCMarathon Petroleum	1.0%	2.9%	2,264	-45.5%	$579K
UPWKUpwork Inc	1.0%	—	67,680	—	$566K
STIMNeuronetics Inc	0.8%	1.1%	369,187	+37.1%	$480K
CGTXCognition Therapeutics Inc	0.7%	0.9%	371,701	-13.8%	$427K
PPCPilgrims Pride Corp	0.7%	3.3%	13,721	-56.3%	$386K
MLPMaui Ld & Pineapple Inc	0.6%	0.2%	19,362	+258.8%	$344K
AIRSAirSculpt Technologies, Inc.	0.5%	—	67,360	—	$303K
GGALGrupo Financiero Galicia S.a	0.4%	—	4,220	—	$211K
CALMCal Maine Foods Inc	0.4%	3.2%	2,581	-81.9%	$208K
MOBMobilicom Ltd	0.3%	—	28,245	—	$145K
SNDASonida Senior Living Inc	0.2%	—	3,521	—	$144K
WELLWelltower Inc	0.2%	—	619	—	$140K
APYXApyx Medical Corporation	0.2%	—	30,249	—	$136K
BKDBrookdale Sr Living Inc	0.1%	—	4,571	—	$74K
JANJanus Living Inc	0.1%	—	2,398	—	$69K
TRAWTraws Pharma Inc	0.1%	2.1%	80,574	-80.7%	$68K
ERNAErnexa Therapeutics Inc	0.1%	—	6,000	—	$40K
INVAInnoviva Inc	0.1%	8.0%	1,620	-98.7%	$37K
CIBGrupo Cibest SA Fsponsored ADR 1 ADR Rep	0.1%	—	443	—	$35K
AEMAgnico Eagle Mines Ltd	0.0%	0.2%	165	-39.3%	$26K
COLOGlobal X Fds	0.0%	—	507	—	$21K
HSAIHesai Group	0.0%	—	1,100	—	$20K
RTACRenatus Tactical Acquis	0.0%	0.1%	1,813	+0.0%	$19K
TVATexas Ventures Acquisition-A	0.0%	0.1%	805	-80.0%	$8K

What Dauntless Investment Group, LLC bought and sold in Q2 2026, against Q1 2026.

New positions

Q1 2026's filing was too long to tell new positions apart.

Added to

ADAG Adagene Inc+1444.9% shares
Aeon Biopharma Inc+394.1% shares
KZIA Kazia Therapeutics Ltd+343.7% shares
MLP Maui Ld & Pineapple Inc+258.8% shares
ESTA Establishment Labs Hldgs Inc+172.9% shares
COUR Coursera Inc+154.2% shares
ARMP Armata Pharmaceuticals Inc+125.1% shares
UTI Universal Technical Inst Inc+92.0% shares

Reduced

INVA Innoviva Inc-98.7% shares
CALM Cal Maine Foods Inc-81.9% shares
TRAW Traws Pharma Inc-80.7% shares
TVA Texas Ventures Acquisition-A-80.0% shares
TOI The Oncology Institute Inc-64.6% shares
PPC Pilgrims Pride Corp-56.3% shares
MRX Marex Group PLC-49.2% shares
LINC Lincoln Educational Srvcs-47.8% shares

Left the top 50

Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.

How the holdings did against the S&P 500.

1 year: -10.6% /yr; S&P 500 +14.9%
3 years: —
5 years: —

A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter	13F value	Positions
Q2 2026	$57.7M	64
Q1 2026	$35.6M	61
Q4 2025	$27.2M	53
Q3 2025	$38.1M	42
Q2 2025	$21.3M	61
Q1 2025	$27.1M	46
Q4 2024	$23.7M	50

Questions about Dauntless Investment Group, LLC's portfolio

What stocks does Dauntless Investment Group, LLC own?

Dauntless Investment Group, LLC's latest 13F, for Q2 2026 and filed Aug 13, 2026, lists 64 positions worth $57.7M. The largest are Aeon Biopharma Inc at 15.6%, Femasys Inc (FEMY) at 13.5%, Kazia Therapeutics Ltd (KZIA) at 8.6%, Valero Energy Corp (VLO) at 4.8% and St Joe Company (JOE) at 3.9%.

What did Dauntless Investment Group, LLC buy last quarter?

In Q2 2026, Dauntless Investment Group, LLC added Adagene Inc (ADAG) (+1444.9% shares), Aeon Biopharma Inc (+394.1% shares) and Kazia Therapeutics Ltd (KZIA) (+343.7% shares), compared with its Q1 2026 filing.

What did Dauntless Investment Group, LLC sell last quarter?

In Q2 2026, Dauntless Investment Group, LLC cut from its top 50 Femasys Inc (FEMY), cut from its top 50 Copa Holdings SA (CPA), cut from its top 50 Dole PLC Ord Shs (DOLE), cut from its top 50 Capricor Therapeutics Inc (CAPR), cut from its top 50 Xp Inc (XP), Innoviva Inc (INVA) (-98.7% shares), Cal Maine Foods Inc (CALM) (-81.9% shares) and Traws Pharma Inc (TRAW) (-80.7% shares), compared with its Q1 2026 filing.

When is Dauntless Investment Group, LLC's next 13F filing due?

13F filings are due 45 days after each quarter ends. Dauntless Investment Group, LLC's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.